ServiceNow (NOW)
Verdict history · NOW
Every call Verdix has made on NOW.
While a verdict holds, its return keeps accumulating from the day the call was made — it resets only when the verdict itself changes.
Click any date below to read that write-up
The prior WAIT hinged on a technical breakout trigger — a weekly close above $133 — that has not yet fired. What changed is the panel's composition and the weight of fundamental conviction: two new voices (The Asymmetric Bargainer and The Disruptive-Innovation Seeker) joined, and the intrinsic-value and scuttlebutt cases each landed above $155, giving four of six archetypes a framework-level reason to treat $128 as a buy despite the un-fired trigger. The sole bear objects on valuation, not business quality, which is why the panel can flip to BUY even though the technical scout's WAIT condition remains unmet.
See methodology for how verdicts are produced. Full track record →
Why the panel isn’t ready to call NOW yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NYSE · Enterprise Software (SaaS) · 2026-06-11 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitMEDIUM confidence
Why
ServiceNow falls another 7% to ~$104 on a rate shock and a fresh security-incident disclosure, closing in on the entry the valuation hawks wanted. The quality business is intact; the debate is still about price and proof.Level to watch
Key resistance 107+2.4% from 104.46
The panel's take
Verdict: WAIT · Conviction: MEDIUM · Last price: USD 104.46 (as of 2026-06-11)
ServiceNow has dropped another ~7% since our prior look at $112, pressured by a higher-for-longer rate repricing (a hot jobs print and a 3-year-high CPI) and a newly disclosed security incident — not by any change in the underlying franchise. The quality investors still see one of enterprise software's best businesses; the valuation hawks still want it cheaper, and the slide has carried it to within ~12-15% of the high-$80s zone they've been waiting for. With the chart still in a deepening downtrend and the breach fallout unresolved, the panel's posture remains: wait.
Key levels
Key levels · NOW
USD · as of 2026-06-11Analyst consensus target 142 USD · range 85–226
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key resistance now starts at the reclaimed-or-lost 5-week moving-average area (~$107), then the $115 rejected-rally zone and the ~$131 Supertrend; key support sits at the $98-102 shelf, then the historical accumulation zone at $85-92, with a deeper thesis line near $74. The analyst consensus target spans roughly USD 85 to 226, averaging near USD 142 — well above the market price, even as individual targets have been trimmed.
What legendary investors think
We ran ServiceNow past a panel of six legendary investors' frameworks (signals unchanged from the prior week's full panel; the ~7% lower price brings the value-oriented thresholds closer into view).
The panel · 6 investors
The Scuttlebutt Growth InvestorGrowth (quality)🟢 BullishHigh
Scores 14/15 — Now Assist AI ACV tracking to $1.5B, 44% Q1 FCF margin, zero structural debt issues; an exceptional business whose only question is entry price.
The Disruptive-Innovation SeekerGrowth🟢 BullishHigh
The neutral orchestration layer for enterprise agentic AI (AI Control Tower); cRPO +22.5% shows demand accelerating even as the stock has roughly halved from its high.
The Activist CatalystQuality/Value🟢 BullishHigh
A wide-moat compounder (98% renewals, 120%+ NRR, ~$4.6B FCF) now near ~20x forward free cash flow — the most attractive entry in years; intrinsic value ~$140-165.
The Moat CompounderValue⚫ NeutralMedium
A wonderful franchise, but at ~66x trailing / ~26x forward earnings still no margin of safety; would buy with conviction nearer $85-95 — a level now within reach.
The GARP OperatorGrowth (GARP)⚫ NeutralMedium
A "Fast Grower" with a non-GAAP PEG near 1.2, but the GAAP picture is rich and the Armis deal added debt; reasonable, not a bargain, until the high-$80s.
The Intrinsic-Value ModelerValuation🔴 BearishMedium
On owner-earnings that count heavy stock-comp, base fair value is ~$78; even at $104 the stock sits a touch above that. Genuinely interested at $80-85.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- The business quality is exceptional and undisputed: 98% renewals, 120%+ net revenue retention, ~35-44% FCF margin, 22% revenue growth.
- This week's ~7% drop was macro (rates) plus a contained, newly disclosed security incident — not a deterioration in the franchise or a guidance change.
- The decline has pulled the stock to within striking distance of the value investors' long-stated entry zone.
The real debate
- Stock-based comp: The Intrinsic-Value Modeler counts ~$2B+ of annual SBC as a real cost and lands near $78, while the Scuttlebutt Growth Investor, Disruptive-Innovation Seeker, and Activist Catalyst lean on the ~32% non-GAAP margin and ~20x forward FCF to call it cheap.
- Now vs. lower: the bulls argue ~20x forward FCF is already the discount; the Moat Compounder and GARP Operator want the high-$80s — now only ~12-15% away.
- The new wrinkle: a security-incident disclosure introduces a trust/headline risk to a company whose moat rests on being the enterprise system-of-record — contained so far, but unresolved.
The question it comes down to: Is the slide toward the high-$80s the mispricing the quality investors have been waiting to buy — or does a rate-pressured multiple, plus a fresh security-incident overhang, argue for letting the chart find its floor first?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 104.46 / ~108B |
| P/E (TTM / fwd) | ~66x / ~26x |
| ROE | 13.5% |
| Operating margin | ~13.5% GAAP (~32% non-GAAP) |
| Dividend yield | 0% (no dividend) |
| Debt / equity | 0.21 |
| Free cash flow | USD 1.67B (Q1 2026, 44% margin); 4.58B (FY2025) |
Figures as of Q1 2026 / June 2026; sourced from ServiceNow IR/SEC filings, GuruFocus, MacroTrends, StockAnalysis. Fundamentals unchanged since the prior week; next earnings ~late July.
The bottom line
Nothing about the franchise changed this week — the stock simply got ~7% cheaper as rates repriced high-multiple software and a security-incident disclosure added a headline overhang. That leaves the same tension, now at a lower price: a genuinely high-quality compounder (98% renewals, mid-40s% FCF margins, a credible AI-monetization pivot) whose value investors still want a notch cheaper, against a chart that is still falling and a breach whose fallout is not yet known. What would tip it bullish is the slide reaching the $85-92 zone on capitulation, a clean security-incident resolution, and the Q2 print confirming the growth pivot; what would tip it bearish is the breach escalating, growth decelerating below ~18%, or the $85-92 base failing. With the next earnings ~48 days out and a new Fed chair's first meeting in between, the price is doing the moving while the fundamentals wait their turn.
contact@verdixhq.com · Published 2026-06-11 · Prices as of 2026-06-11 · Time horizon: 3–12 months · Founder holds a direct position in NOW · NOW verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel’s case for NOW — and where they disagree.
The case for outweighs the case against at today's price.
NYSE · Enterprise Software (SaaS) · 2026-06-13 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
BuyMEDIUM confidence
Why
After a ~56% fall to ~$93, the value investors who spent months saying 'wait for the high-$80s' just flipped to buyers. Five of six panel archetypes now see a wonderful business at a fair price — while the broken chart argues for patience on timing. The debate and the key levels.Level to watch
Key support 88−4.9% from 92.57
The panel's take
Verdict: BUY · Conviction: MEDIUM · Last price: USD 92.57 (as of 2026-06-13)
This is the first time the panel has turned constructive on ServiceNow. The stock has fallen ~56% from its post-split high to ~$93 — into the exact zone the value archetypes had named as their entry — and the two anchors who set that bar, the Moat Compounder and the GARP Operator, have flipped from "wait" to buyers, joining the Scuttlebutt Growth Investor, the Disruptive-Innovation Seeker, and the Activist Catalyst. At ~24x forward earnings and a PEG below 1, a 22%-growth, 98%-renewal franchise is now cheaper than slower-growing peers. The lone holdout, the Intrinsic-Value Modeler, wants a touch lower still, and the chart is in a confirmed downtrend with no reversal signal yet — which is why the bullish case favours accumulating into weakness rather than chasing.
Key levels
Key levels · NOW
USD · as of 2026-06-13Analyst consensus target 142 USD · range 100–226
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Current price sits inside the $85–92 historical accumulation zone the value archetypes had targeted; key support runs to the $81 area (the 52-week low) and a deeper $74 zone, while key resistance starts at the round $100 level, then the ~$107 moving-average and the ~$131 Supertrend overhead. The analyst consensus target spans roughly USD 100 to 226, averaging near USD 142 — well above the market price, even after targets were trimmed.
What legendary investors think
The panel · 6 investors
The Scuttlebutt Growth InvestorGrowth (quality)🟢 BullishHigh
14/15 business quality; "the price changed, not the company." At ~24x forward earnings and ~4.7% FCF yield, a 50%-off entry into a system-of-record franchise — the security incident is a monitor item, not a sell signal.
The Activist CatalystQuality/Value🟢 BullishHigh
A wide-moat compounder (98% renewals, $4.6B FCF) now at ~17x forward FCF with management buying back stock aggressively into the lows — "a generational opportunity at a historically attractive valuation... we are buyers."
The Disruptive-Innovation SeekerGrowth🟢 BullishHigh
The neutral orchestration layer for enterprise agentic AI; at ~9x EV/revenue (41% below its 10-year median) on a 22% grower, the mispricing has only widened — though the breach trims conviction.
The Moat CompounderValue🟢 BullishMedium
"The price has finally come down to meet a wonderful business." At ~18x adjusted owner-earnings the prior $85–95 buy zone is met — would begin building, keeping dry powder for $80–85.
The GARP OperatorGrowth (GARP)🟢 BullishMedium
A PEG of ~0.97 — below 1.0 for the first time in years on a "Fast Grower" with $27.7B of contracted backlog. "Does $92.57 meet my threshold? Yes, explicitly."
The Intrinsic-Value ModelerValuation🔴 BearishMedium
An owner-earnings DCF lands near $99 base value — only ~7% above the price; "insufficient margin of safety. My $80–85 interest zone remains." The lone hold-out.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- The business is exceptional and intact: 22% revenue growth, 98% renewals, ~35% FCF margins, $27.7B remaining performance obligations (+25%), and a raised $30B-by-2030 roadmap.
- The ~56% drawdown is multiple compression plus a confluence of shocks (rate pressure, a security incident, Armis margin drag) — not a fundamental break.
- At ~24x forward earnings / PEG ~0.97, the valuation has de-rated to the most attractive level in years — cheaper than slower-growing Salesforce and Workday.
The real debate
- Is the price finally right? The Moat Compounder and the GARP Operator — who set the "high-$80s/$85–95" bar — say yes and have flipped to buyers; the Intrinsic-Value Modeler says it's still ~7% above the $80–85 margin-of-safety zone.
- Business vs. the chart: the value case has tipped bullish, but the technical picture is a confirmed downtrend with no reversal signal yet — the price reached the zone but the selling has not visibly exhausted.
- The security incident: a reputational dent that complicates the "AI governance" sales pitch for a quarter or two (the panel's read), versus a potential trust-erosion cycle (the risk to monitor at the July 29 earnings call).
The question it comes down to: With the value archetypes' long-awaited entry zone finally reached and confirmed, is this the mispricing to accumulate — or does a falling chart and an unresolved Q2 (security fallout + Armis margins) argue for waiting for the selling to exhaust first?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 92.57 / ~95B |
| P/E (TTM / fwd) | ~61x / ~24x |
| ROE | 18% |
| Operating margin | ~13.5% GAAP (~31.5% non-GAAP) |
| Dividend yield | 0% (no dividend) |
| Debt / equity | 0.15 (pre-Armis; modest net debt post-deal) |
| Free cash flow | USD 1.67B (Q1 2026, 44% margin); 4.6B (FY2025) |
Figures as of Q1 2026 / June 2026; sourced from ServiceNow IR/SEC filings, GuruFocus, StockAnalysis, MacroTrends. Reported TTM GAAP P/E is depressed by ~$2.2B annual stock-based compensation; next earnings July 29.
The bottom line
For the first time, the weight of the panel's analysis on ServiceNow tilts to buy. The franchise never broke — 22% growth, 98% renewals, $27.7B of contracted backlog, a $30B 2030 roadmap — but a ~56% drawdown driven by rate pressure, a security incident, and Armis-related margin drag has finally pulled the price into the zone the value archetypes spent months waiting for, and the two who set that bar have crossed over: at a PEG below 1 and ~24x forward earnings, a faster-growing business now trades below its slower-growing peers. The counterweights are about timing, not merit — the lone valuation hold-out wants ~7% lower, the chart shows no sign yet that the selling is done, and the July 29 quarter must confirm the security incident didn't dent renewals and that Armis margins are tracking. That tension is why the constructive case favours accumulating into the weakness with reserves rather than committing all at once. What would push it decisively bullish is a clean Q2 with renewals holding at 98% and a credible security-remediation message; what would reopen the bear case is renewal slippage, a second incident, or a break of the $81 low.
contact@verdixhq.com · Published 2026-06-13 · Prices as of 2026-06-13 · Time horizon: 3–12 months · Founder holds a direct position in NOW · NOW verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel’s case for NOW — and where they disagree.
The case for outweighs the case against at today's price.
NYSE · Enterprise Software (SaaS) · 2026-07-11 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
BuyMEDIUM confidence
Why
Six investing legends on the enterprise-software name the market re-priced as an AI casualty: a ~53% de-rating on 'AI kills SaaS' fear, set against subscription revenue still growing 22%, agentic-AI bookings raised from $1B to $1.5B, and a 97-98% renewal rate. Most fair values sit 30-44% above the price — the debate is timing, not the business. The panel and the key levels.Level to watch
Key support 100−7.2% from 107.71
The panel's take
Verdict: BUY · Conviction: MEDIUM · Last price: USD 107.71 (as of 2026-07-11)
ServiceNow is the panel's clearest "the tape and the fundamentals have diverged" call. The stock has fallen 53% from its early-2025 high ($230 post-split) to a ~$90 low and bounced to $107.71 — cut roughly in half not on a broken business but on a narrative: the "SaaSpocalypse" thesis that AI agents will hollow out seat-based software. The numbers point the other way. Subscription revenue grew 22% in Q1, cRPO (the committed-backlog metric) rose ~21% in constant currency, the Now Assist agentic-AI annual-contract-value target was raised from $1B to $1.5B for 2026, $1M+ ACV customers grew 130% year over year, and the renewal rate held at 97-98%. On July 1 the company simplified its five license tiers into three AI-native bundles and Guggenheim upgraded to Buy the next day. Five of six lenses — fundamental, GARP, disruptive-innovation, intrinsic-value, and sentiment — land bullish with fair values between roughly $126 and $160 (+30% to +44%); the Moat Compounder and the Macro Opportunist are constructive but want confirmation; only the Forensic Skeptic is neutral, flagging stock-based-comp that makes the "cheap" business less cheap than it looks. What keeps this MEDIUM rather than HIGH: the chart is broken, the Fed is hawkish, and the whole thesis has a dated test — Q2 earnings on July 22. On the weight of an accelerating franchise priced for decline, the synthesis is BUY.
Key levels
Key levels · NOW
USD · as of 2026-07-11Analyst consensus target 143 USD · range 85–236
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key resistance starts at ~$123 (the 23.6% retracement of the decline and nearest overhead supply), then ~$143-145 (the 38.2% retracement, which also sits on the analyst-consensus average), up to the ~$160 shelf (the 50% retracement) — reclaiming ~$123 on multi-week volume is the level several lenses treat as the "downtrend is over" trigger. Key support sits at ~$100 (a round number and the reflex-bounce origin), then ~$90 (the capitulation low), with a deeper structural level near ~$78-80. The analyst consensus target spans a very wide USD 85 to 236, averaging near USD 143 — well above the current price (a ~33% gap) even as the Street compressed targets ~24% over three months while keeping Buy ratings, which reads as a multiple reset rather than a downgrade.
What legendary investors think
We ran ServiceNow past a panel of six legendary investors' frameworks.
The panel · 6 investors
The Moat CompounderValue⚫ NeutralMedium
A real switching-cost moat — "wired into the customer's IT, HR, and customer-service plumbing," 77% gross margin, low debt. Forward P/E ~20.6x is reasonable for 22% growth, "but the trailing GAAP multiple near 53x tells you stock-based comp is inflating the free-cash-flow story and diluting the owner." ROE of 13-16% is below the 20%+ he wants from a "wonderful" business. "Fairly priced after the fall, not a bargain" — would get greedy in the $80s with GAAP converging toward non-GAAP.
The GARP OperatorGrowth (GARP)🟢 BullishMed-High
A fast-grower maturing into a stalwart, "smashed on a story, not the numbers." FY26 guidance of ~21% constant-currency subscription growth, EPS +19%, a forward PEG around 0.83-1.1 — "a sub-1 PEG on a 20%-plus grower of this quality is the kind of mispricing you wait years for." Net cash ~$5.5B, renewal 97%, $1M+ ACV customers +130%. Bear flag: renewal slipping below 94-95% or two quarters of net-new ACV deceleration.
The Disruptive-Innovation SeekerGrowth🟢 BullishMedium
"A category-error selloff — the market priced ServiceNow as an AI *casualty* when it's an AI *platform*." Subscription revenue +22%, Now Assist ACV raised $1B→$1.5B, the new AI Control Tower is a fresh layer that polices enterprise AI agents. "Wright's Law runs in reverse here — cheaper automation means *more* workflows, not fewer." Consumption-AI revenue is outgrowing seat revenue: re-platforming ahead of the disruption, not a victim of it.
The Intrinsic-Value ModelerValuation🟢 BullishMedium
A story-to-numbers DCF (10% WACC, 22% growth, ~38% FCF margins) puts base fair value at ~$150-160 — "18.75x EV/FCF for this growth-and-margin profile, versus a 28-35x history, says the re-rate overshot on fear." Bear ~$95-100, base ~$155, bull ~$210-220 — "the current price is basically the bear case." Margin of safety is present because the disruption risk is real, not zero.
The Forensic SkepticContrarian🔴 BearishMedium
"Not a value stock — a growth stock that's 53% cheaper and *still* priced like a growth stock." 7.4x EV/sales and ~24x price-to-free-cash-flow, but stock-based comp near $2B (15% of revenue) means true owner earnings are closer to $2.6B — a ~2.3% SBC-adjusted yield. cRPO decelerating 21%→19.5% and real agentic seat-compression risk keep him off the long side. The green tell: "CEO bought $3M in the open market in February and ended his 10b5-1 plan." An overshoot toward fair value, not past it into a bargain — sidelines, not short.
The Macro OpportunistMacro🟢 BullishLow-Med
"Price collapsed on a narrative the fundamentals didn't confirm — that's my kind of setup, but one +4% bounce after a 53% fall is a data point, not a trend." The Fed is on hold at 3.5-3.75% with hikes on the table, "a liquidity headwind for anything trading on a high multiple." A small starter here; adds aggressively only if the July 22 print confirms *and* the stock reclaims the 50-day/$95-100 on volume and breaks the 200-day.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- The ~53% de-rating was driven by a narrative (AI agents hollowing out seat-based SaaS), and the operating metrics never confirmed it — subscription revenue +22%, cRPO +21% cc, renewal 97-98%.
- The agentic-AI motion is accelerating, not stalling: Now Assist ACV target raised $1B→$1.5B, $1M+ ACV customers +130%, and over half of net-new ACV is now consumption/non-seat priced.
- The valuation has reset to reasonable-or-cheap on forward numbers: ~20-21x forward earnings, a PEG below 1, EV/sales of 7.4x (below the SaaS-peer median ~8.5x).
- The overhangs are real: the chart is in a confirmed downtrend below the 200-week, the Fed is hawkish, and stock-based comp inflates the headline cash-flow picture.
The real debate
- Is it cheap, or just less expensive? The GARP, intrinsic-value, and disruptive lenses see a 30-44% gap to fair value; the Forensic Skeptic counters that SBC-adjusted owner earnings make the ~24x cash-flow multiple much less of a bargain.
- Does agentic AI expand or compress ServiceNow? Bulls say cheaper automation multiplies workflows and ServiceNow sells the control layer; the skeptic flags that seat-based pricing is exactly what agents threaten (management's hedge: >50% of new business is usage-priced).
- Buy the fundamentals or wait for the tape? Value and macro lenses want a reclaim of $95-100 (or the July 22 print) before sizing up; the growth lenses argue a sub-1 PEG on a 20%+ grower doesn't wait for permission.
The question it comes down to: Is ServiceNow an accelerating, 97%-renewal enterprise platform the market mistakenly re-priced as an AI casualty — a rare sub-1-PEG mispricing of a wonderful business — or a still-expensive growth stock whose stock-based comp, decelerating backlog, and broken chart argue for waiting until the July 22 print confirms the fear was wrong?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 107.71 / ~111B |
| P/E (fwd / trailing GAAP) | ~20.6x / ~53x (SBC-heavy) |
| Subscription revenue growth | +22% YoY (Q1'26; +19% cc) |
| cRPO | USD 12.64B, +21% cc |
| FY26 subscription guide | USD 15.735–15.775B (+20.5–21% cc; raised ~$205M) |
| Gross / FCF margin | ~77% / ~35% (guided); Q1 FCF $1.665B (44% margin) |
| Now Assist ACV target | Raised USD 1.0B → 1.5B for 2026; $1M+ ACV customers +130% YoY |
| Renewal rate | 97–98% |
| Balance sheet | Net cash ~$5.5B; D/E 0.21 |
| Valuation | EV/sales 7.4x (vs SaaS-peer median ~8.5x); EV/FCF ~18.75x; PEG ~0.83 |
Figures as of Q1 2026 (reported ~Apr 22-23) / July 11, 2026; sourced from ServiceNow IR/SEC filings, Investing.com, StockAnalysis, MarketBeat, GuruFocus. The stock fell ~14% on the April print — a beat-and-raise overshadowed by a "SaaSpocalypse" software-sector selloff (Anthropic's Cowork agent launch triggered an estimated $285B software wipeout over 48 hours in February 2026) and Q1 subscription gross-margin optics (84.5%→81.5% on AI-infra cost). On July 1 the company collapsed five license tiers into three AI-native bundles (Foundation/Advanced/Prime plus Now Assist, AI Control Tower, Workflow Data Fabric); Guggenheim upgraded to Buy on July 2. Institutions are net buyers (~87% institutional ownership); short interest ~5.9%; put/call ~0.27 (call-skewed). The stock did a 5-for-1 split in December 2025. Next print: July 22, 2026.
The bottom line
ServiceNow is the panel's highest-conviction "buy the divergence" call this cycle — an accelerating enterprise franchise the market re-priced as an AI casualty. The bull case is unusually clean: subscription revenue is still compounding 22%, cRPO is up 21% in constant currency, the renewal rate held at 97-98%, and management raised the Now Assist agentic-AI target from $1B to $1.5B while $1M+ ACV customers grew 130% — none of which is the behavior of a business being disrupted. Against that, the stock fell ~53% on a narrative, leaving it at ~20x forward earnings and a sub-1 PEG, which is why the fundamental, GARP, disruptive-innovation, and intrinsic-value lenses all land fair value between roughly $126 and $160 and the Street consensus sits near $143. The cautions are real but second-order: the Forensic Skeptic is right that ~$2B of stock-based comp makes the cash-flow multiple less of a steal than the headline; the Moat Compounder would rather buy in the $80s with GAAP converging to non-GAAP; and the Macro Opportunist won't size up into a broken chart and a hawkish Fed until the tape confirms. What would settle it is the July 22 print — another quarter of 20%+ subscription growth with renewal and ACV intact, plus a reclaim of the $95-100 zone on volume, would turn the constructive holdouts into buyers. What keeps it MEDIUM rather than HIGH is precisely that the confirmation hasn't happened yet: the business case is made, the tape hasn't agreed, and one bounce off the lows is not a trend. But with five of six lenses pointing 30-44% higher and the price sitting near the modeled bear case, the balance of evidence favours accumulating a franchise the market mistook for a victim of the very technology it sells.
contact@verdixhq.com · Published 2026-07-11 · Prices as of 2026-07-11 · Time horizon: 3–12 months · Founder holds a direct position in NOW · NOW verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
Why the panel isn’t ready to call NOW yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NYSE · Enterprise Software (SaaS) · 2026-07-18 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitMEDIUM confidence
Why
Six investing legends revisit ServiceNow four days before its Q2 print: the business case is unanimous — 22% subscription growth, 97-98% renewal, a raised $1.5B agentic-AI target — but the stock just failed to hold a reclaim of $123 and round-tripped from $138-141 back to $103. Two lenses say the mismatch is already big enough to act on; four say wait for the July 22 earnings print or a volume-backed reclaim first. The debate and the key levels.Level to watch
Key support 100−3.1% from 103.24
The panel's take
Verdict: WAIT · Conviction: MEDIUM · Last price: USD 103.24 (as of 2026-07-18) · Changed from BUY
What changed since 2026-07-11:
- Price: USD 107.71 → 103.24 (-4.1%) — a spike to $138-141 failed to hold the $123 resistance zone and round-tripped back down to retest $100-103.
- Panel: 3 of 6 → 2 of 6 now Bullish (the Intrinsic-Value Modeler flipped from Bullish to Neutral) — the DCF case now wants the July 22 print to confirm the discount before calling it a buy.
- Trigger: the Q2 earnings print on July 22, or a volume-backed close back above the $123 resistance zone.
- Verdict: BUY → WAIT
ServiceNow's business case remains undisputed across all six lenses — 22% subscription growth, 97-98% renewal, and a Now Assist target raised to $1.5B, none of which has moved since last week. What tipped the synthesis from BUY to WAIT is that the tape still hasn't confirmed the story: two lenses treat the pullback as noise around an already-actionable mispricing, while four want the July 22 print or a volume-backed reclaim of $123 before committing fresh capital — a price-and-timing debate, not a business-quality one.
Key levels
Key levels · NOW
USD · as of 2026-07-18Analyst consensus target 143 USD · range 85–236
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key resistance starts at ~$123 — the level the stock spiked through to $138-141 two weeks ago and then failed to hold, making it the level several lenses now treat as the confirmation trigger — then ~$143-145 (also near the analyst-consensus average), up to the ~$160 shelf. Key support sits at ~$100, a round number this week's retreat is retesting directly, then ~$90 (the prior capitulation low), with a deeper structural level near ~$78-80. The analyst consensus target still spans a wide USD 85 to 236, averaging near USD 143 — roughly 38% above the current price.
What legendary investors think
We ran ServiceNow past a panel of six legendary investors' frameworks.
The panel · 6 investors
The Moat CompounderValue/Quality/Moat⚫ NeutralMedium
Renewal at 97-98%, 22% subscription growth, net cash, and 13-16% ROE aren't the marks of a broken company — "a 53% de-rating on a story the operating results never confirmed does smell like Mr. Market being emotional." But with the stock still below its own Supertrend line at $103 and the $123 reclaim already failed once, he won't commit fresh capital into the binary of a July 22 print four days out.
The GARP OperatorGrowth (GARP)🟢 BullishMedium
Subscription revenue +22%, cRPO +21% cc, 97-98% renewal, and the Now Assist target raised $1.0B→$1.5B — "a company growing, not one being killed by AI." A PEG near 0.80 at 19.8x forward earnings, net cash of $5.5B, D/E of 0.21, and $1.665B of quarterly free cash flow is a mismatch he'd rather own now than wait on: "the chart just tells me Mr. Market hasn't done his homework yet."
The Disruptive-Innovation SeekerDisruptive Innovation🟢 BullishMedium
The AI-platform economics are accelerating even as the market priced in an "AI kills SaaS" narrative the data doesn't support — subscription +22%, cRPO +21% cc, $1M+ ACV customers +130% YoY. On a PEG of 0.80 and EV/FCF of 18x against 44% FCF margins, "this is a platform compounder trading like a melting ice cube," and the failed breakout to $138-141 reads as weak hands shaking out before the July 22 catalyst confirms the thesis already visible in the numbers.
The Intrinsic-Value ModelerValuation/DCF⚫ NeutralMedium
The 22% subscription growth and 97-98% renewal "simply don't support a stock that fell 53% peak to trough," but at $103.24 with EV/sales still near 7.1x and a trailing GAAP P/E north of 51x, the tape isn't handing him the discount its own chart pattern implies. The failed breakout above $123 and round-trip to retest $100 tells him "price is waiting for the July 22 print, and so should my conviction."
The Forensic SkepticContrarian/Forensic⚫ NeutralLow
"The footnotes haven't been written yet" — every number in this brief is a Q1 carry-forward four days ahead of the print. The setup is real (97-98% renewal, cRPO +21% cc, EV/FCF ~18x against $5.5B net cash isn't expensive if growth holds), but he won't pay for a thesis before the data that tests it: "this is a WAIT, not a BUY — get the print, get a close back above $123 on volume, then size up."
The Macro OpportunistMacro/Timing⚫ NeutralLow
Fundamentals — 22% subscription growth, 21% cRPO, 97-98% renewal — are fine, but "fine fundamentals with a broken chart is exactly the setup where I get run over if I size up before the tape confirms." Supertrend stays bearish below $130 after the failed reclaim of $123; he'd rather lose the first 10% of a confirmed move than front-run a binary Q2 print, and turns aggressive only on a post-earnings close above $123 on volume.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- The operating business is unanimously fine: subscription revenue +22% YoY, cRPO +21% cc, renewal 97-98%, net cash $5.5B, and the Now Assist agentic-AI target raised from $1.0B to $1.5B — none of the six lenses dispute these figures.
- The chart has not confirmed the fundamental story: the spike to $138-141 failed to hold, the $123 reclaim reversed, and the stock is back retesting $100-103, still below its Supertrend line near $130.
- The July 22 Q2 print is the shared reference point every lens is measuring against, bullish or not.
The real debate
- Act now on the mispricing, or wait for the tape to agree? The GARP Operator and Disruptive-Innovation Seeker see a PEG near 0.80 on a 20%+ grower as already actionable; the Moat Compounder, Intrinsic-Value Modeler, Forensic Skeptic, and Macro Opportunist all want either the earnings print or a volume-backed reclaim of $123 first.
- Is this price/timing hesitation, or a change in business view? None of the four neutral voices point to a deteriorating metric — their reasoning is explicitly about the binary event risk and the failed breakout, not the renewal rate or the growth numbers.
The question it comes down to: With the business case unchanged and unanimous, does the failed $123 reclaim and four days to a binary earnings print argue for waiting on confirmation, or is the PEG-near-0.80 mismatch already wide enough that waiting just means paying up later?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 103.24 / n/a |
| P/E (fwd / trailing GAAP) | ~19.8x / ~51x |
| Subscription revenue growth | +22% YoY (Q1'26) |
| cRPO | +21% cc |
| Renewal rate | 97–98% |
| ROE | 13–16% |
| Now Assist ACV target | Raised USD 1.0B → 1.5B for 2026; $1M+ ACV customers +130% YoY |
| Balance sheet | Net cash ~USD 5.5B; D/E 0.21 |
| Free cash flow | USD 1.665B (Q1'26) |
| Valuation | EV/sales ~7.1x; EV/FCF ~18x; PEG ~0.80 |
Figures as of Q1 2026 (reported ~Apr 22-23) carried forward to July 18, 2026, four trading days ahead of the Q2 print scheduled July 22, 2026; sourced from ServiceNow IR/SEC filings, Investing.com, StockAnalysis, MarketBeat, GuruFocus.
The bottom line
The July 22 print is the fulcrum: another quarter of 20%+ subscription growth with renewal and cRPO intact, paired with a volume-backed close back above $123, would likely convert the four neutral lenses into buyers and could re-open a BUY call within days. Conversely, any crack in renewal (below 94-95%) or a second failed attempt at $123 would harden the neutral stance into an extended WAIT rather than resolve it quickly. Watch the $100 support directly below current price — a decisive break would test the prior capitulation low near $90 before the earnings data even arrives.
contact@verdixhq.com · Published 2026-07-18 · Prices as of 2026-07-18 · Time horizon: 3–12 months · Founder holds a direct position in NOW · NOW verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
Why the panel isn’t ready to call NOW yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NYSE · Enterprise Software (SaaS) · 2026-07-25 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitMEDIUM confidence
Why
Six lenses revisit ServiceNow three days after a clean Q2 beat-and-raise — subscription growth accelerated to 24.5%, AI ACV crossed $1B, guidance raised — and four of six flipped Bullish on the print alone. But the tape did the opposite of what last week's WAIT was waiting for: shares broke the $100 floor, pierced into the low-$90s, and closed near $98.78, down another 4.3% from last week's snapshot. The debate and the key levels.Level to watch
Key support 98−0.8% from 98.78
The panel's take
Verdict: WAIT · Conviction: MEDIUM · Last price: USD 98.78 (as of 2026-07-25)
What changed since 2026-07-18:
- Price: USD 103.24 → 98.78 (-4.3%) — the stock broke below its own $100 support, pierced intraweek to $91.53 on the July 22 earnings reaction (tagging the S2 zone directly for the first time since April), then closed back near $98.78, right at the floor of the S1 band.
- Panel: 2 of 6 → 4 of 6 now Bullish (The Moat Compounder, The Disruptive-Innovation Seeker, and The Intrinsic-Value Modeler all flipped from Neutral to Bullish, joining The GARP Operator, who upgraded Medium → High) — but The Macro Opportunist moved the other way, Neutral to Bearish.
- Catalyst: the July 22 Q2 print landed clean — subscription revenue accelerated to +24.5% YoY (from 22%), cRPO +21%, non-GAAP EPS $0.90 beat estimates, Now Assist AI crossed $1B in annual contract value, and FY26 guidance was raised — yet the stock fell further rather than reclaiming the $123 trigger the panel had flagged.
- New risk: ServiceNow's balance sheet flipped to a net-debt position (~USD -1.2B) following the debt-financed $7.8B Armis acquisition, a leverage step-up not present in the July 18 view; stock-based comp also rose 31% YoY.
- Verdict: WAIT (unchanged) — the fundamental half of last week's two-part trigger was satisfied; the price half failed, and it failed in the direction opposite to what would have resolved the thesis.
The business case got stronger this week, not weaker, and four lenses now treat the July 22 print itself as sufficient confirmation to act. But the price condition the panel actually set last week — a volume-backed reclaim of $123, or at minimum the tape rewarding the print — was not met; instead the stock broke a round-number support it had been defending and briefly traded into its own capitulation zone before recovering. That's a genuine widening of the fundamentals-versus-tape mismatch the panel debated on July 18, not a resolution of it, which is why the synthesis holds at WAIT even with a majority-Bullish panel underneath it.
Key levels
Key levels · NOW
USD · as of 2026-07-25Analyst consensus target 140 USD · range 85–236
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key resistance still starts at ~$120–126 — the failed-reclaim zone from June that remains the confirmation trigger several lenses are watching — but a nearer supply shelf has emerged since: the July 6 bounce high (close $107.71, intraweek $113.79) is now the first hurdle to clear before $120–126 is even in play. Support sits at ~$98–105, the historical accumulation band the stock is currently defending after an intraweek pierce to $91.53; that wick tagged the ~$88–92 prior-capitulation zone directly and held, the first real test of that level since April. A deeper structural floor sits near ~$78, still untested. The analyst consensus target moved up slightly to an average near USD 140 (range still USD 85–236, ~42% above current price), with several banks raising targets specifically on the July 22 print.
What legendary investors think
We ran ServiceNow past a panel of six legendary investors' frameworks.
The panel · 6 investors
The Moat CompounderValue/Quality/Moat🟢 BullishMedium
Subscription growth stepping up to 24.5% YoY, non-GAAP operating margin pushing toward 30%, and Now Assist crossing $1B in ACV, all while the stock closed *lower* than last week — "when the business accelerates and the price still falls, that's not the market telling you something's wrong, that's the market handing you a wider margin of safety and asking if you're paying attention." Trailing GAAP P/E near 62x and no volume-backed reclaim of resistance keep him at Medium, not High.
The GARP OperatorGrowth (GARP)🟢 BullishHigh
A grower that reaccelerates into its print instead of decelerating is the exact tell he looks for — subscription +24.5%, EPS $0.90 beating estimates, AI ACV past $1B — so the PEG math stays sub-1.0 even after the bounce. "The stock finally got the permission slip it was waiting for — now the question is whether the price bothers to read it."
The Disruptive-Innovation SeekerDisruptive Innovation🟢 BullishMedium
The "AI kills SaaS" bear case priced into a 35%+ drawdown is being falsified in real time — subscription accelerating, agentic-AI production deployments up 9x in nine months, guidance raised. "The market spent a year pricing ServiceNow as AI's victim; Q2 just showed it's AI's distribution layer."
The Intrinsic-Value ModelerValuation/DCF🟢 BullishMedium
At ~$98.78 versus ~$103.24 last week, EV/sales has compressed to roughly 6.7x on a business still growing subscription north of 20%, but cRPO guidance stepping down to 19.5% cc and margin guidance trimmed are real cracks in his terminal-value assumptions, not noise. "The market is now pricing a deceleration that's real, but pricing more of it than the numbers actually support."
The Forensic SkepticContrarian/Forensic⚫ NeutralLow
The print was clean on its face, but stock-based comp rose 31% YoY to 16% of revenue and the FY guide implies deceleration off a 24.5% quarter — footnotes he wants explained before trusting the headline. "The market got the print it said it wanted and sold it anyway, and that tells me more than the print itself does."
The Macro OpportunistMacro/Timing🔴 BearishMedium
A company that beats top and bottom line and still can't hold $100 into a hawkish FOMC is the market pricing the discount rate, not the business — plus a quality-of-beat wrinkle around pulled-forward government revenue. "I don't pay for a beat the tape refuses to reward — that's the market pricing in something I'm not seeing yet."
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- The Q2 print itself is undisputed: subscription revenue +24.5% YoY, cRPO +21%, non-GAAP operating margin ~29.5%, EPS beat, Now Assist AI past $1B in ACV, FY26 guidance raised — no lens contests these figures.
- The tape did not reward the beat: shares broke the $100 support flagged last week, traded intraweek into the low-$90s, and closed the week lower than the July 18 snapshot — every lens agrees on this fact, even the four that turned Bullish on it.
- The $120–126 reclaim trigger from July 18 remains unmet; nobody claims it has fired.
The real debate
- Is the earnings print itself the confirmation, or is the tape's refusal to hold $100 the more important signal? The Moat Compounder, GARP Operator, Disruptive-Innovation Seeker, and Intrinsic-Value Modeler now treat the beat-and-raise as sufficient to act on; the Forensic Skeptic and Macro Opportunist argue the market answered only half the trigger and that a beat the tape sells anyway is itself the data point that matters more.
- New risk, differently weighted: the swing to a net-debt balance sheet from the Armis acquisition and the 31% YoY rise in stock-based comp are flagged by the Forensic Skeptic and Intrinsic-Value Modeler as fresh complications for the thesis; the growth-focused lenses treat them as second-order relative to the accelerating top line.
- Macro overlay: the Macro Opportunist reads a hawkish FOMC and SaaS-sector contagion (a weak peer print, an AI-budget-shift warning) as a decisive headwind for long-duration growth names like this one; the other five lenses largely set that overlay aside in favor of the company-specific data.
The question it comes down to: does a beat-and-raise that the market still sells count as the confirmation the July 18 WAIT was waiting for, or does the tape's continued refusal to hold $100 — now paired with a genuine new leverage step-up from Armis — mean the price condition of that trigger still hasn't been met?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 98.78 / n/a |
| P/E (trailing GAAP) | ~62x |
| Subscription revenue growth | +24.5% YoY (Q2'26, vs +22% Q1'26) |
| cRPO | +21% YoY |
| Renewal rate | 97–98% (last confirmed Q1'26; no lens flags a change this week) |
| ROE | ~15–16% |
| Now Assist ACV | Crossed USD 1B in Q2, on pace for the raised USD 1.5B FY26 target; $1M+ ACV deals +~40% YoY |
| Balance sheet | Net debt ~USD -1.2B (cash + securities USD 6.28B vs. total debt USD 7.52B); D/E ~0.58 — reversal from net cash ~USD 5.5B / D/E 0.21 cited Q1'26, driven by the debt-financed USD 7.8B Armis acquisition |
| Free cash flow | USD 634M (Q2'26, non-GAAP) vs. USD 1.665B (Q1'26) — a normal seasonal dip pending next-quarter confirmation |
| Valuation | EV/sales ~6.7x; PEG sub-1.0 on the accelerated growth rate; analyst consensus target ~USD 140 average (range USD 85–236) |
Figures as of Q2 2026 (reported July 22, 2026), current as of July 25, 2026; sourced from ServiceNow Newsroom Q2 2026 Financial Results, SEC 10-Q (filed 2026-07-23), SEC 424B2 prospectus supplement (2026-05), StockAnalysis, Macrotrends, GuruFocus, Benzinga.
The bottom line
The fundamentals moved decisively in one direction this week and the price moved in the other — a wider version of the same mismatch the panel debated on July 18, not a resolved one. A weekly close that reclaims the nearer $108–114 supply shelf on rising volume, followed by progress toward $120–126, would likely convert the two remaining skeptical lenses and open a path back to BUY. Conversely, a decisive weekly close below $98 — through the S1 floor this week's bar is currently defending — would put the $88–92 zone back in play and would harden the case the Macro Opportunist is already making. Until one of those happens, the print has strengthened the story without yet moving the tape enough to act on it.
contact@verdixhq.com · Published 2026-07-25 · Prices as of 2026-07-25 · Time horizon: 3–12 months · Founder holds a direct position in NOW · NOW verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
Why the panel isn’t ready to call NOW yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NYSE · Enterprise Software (SaaS) · 2026-08-02 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitMEDIUM confidence
Why
ServiceNow's post-earnings selloff is unwinding — the stock recovered 12.6% off its July 25 low to $111.23, reclaiming its weekly 20-week EMA even as the monthly trend stays in a confirmed downtrend. Five of six investor archetypes now call the business bullish outright, with only the valuation-discipline lens holding out for a wider margin of safety. The debate has moved from 'is the AI-disruption fear real' (the panel says no) to 'has this recovery earned a technical base yet.'Level to watch
Key support 103.28−7.1% from 111.23
The panel's take
Verdict: WAIT · Conviction: MED · Last price: USD 111.23
What changed since 2026-07-25:
- Price: USD 98.78 → 111.23 (+12.6%) — a continued recovery off the post-Q2-earnings, OpenAI-"Presence"-selloff low, with the weekly chart reclaiming its 20-week EMA and posting a bullish MACD crossover, even as the monthly trend remains in a confirmed Stage 4 downtrend (price still ~54% below the all-time high).
- Panel: 4 of 6 → 5 of 6 now Bullish — composition also changed: added The Scuttlebutt Growth Investor; removed The Macro Opportunist. Within the retained archetypes, The Intrinsic-Value Modeler flipped Bullish → Neutral (the recovery narrowed the margin of safety) while The Forensic Skeptic flipped Neutral → Bullish (now reads the post-earnings selloff as a classic contrarian entry, not a warning sign).
- Trigger: BUY on a monthly close above USD 133.19 (61.8% Fibonacci retracement), confirming the Stage 4-to-Stage 1 transition — or a pullback toward USD 90 that satisfies the price-discipline lens's margin-of-safety threshold. SELL if renewal rate drops below 95%, cRPO growth falls below 15% constant-currency, or a weekly close breaks below USD 103.28 (the volume point-of-control), negating the base-building thesis.
- Verdict: WAIT (unchanged)
The business case has been essentially settled for two weeks running — a clean Q2 beat-and-raise, a 98% renewal rate, AI net new ACV crossing $1B ahead of schedule, and a CEO who put $3M of his own money into the stock in February all point the same direction. What's shifted since July 25 is that the price is finally starting to agree: a 12.6% bounce has the weekly chart forming an early base, even as the monthly downtrend — the more important timeframe for a position investor — has not yet reversed. That's the same fundamentals-versus-tape gap the panel has been tracking for three weeks, just narrower than it was.
WAIT over BUY because the two cautious voices — the technical read and The Intrinsic-Value Modeler — both object on price and timing, not business quality: the technical scout wants to see the monthly downtrend actually break before calling this recovery a reversal, and the DCF-based lens sees only a 14% gap between its base-case fair value ($125) and the current price, too thin a cushion given a genuinely two-sided narrative risk (AI disruption vs. AI entrenchment) that hasn't fully resolved either way. WAIT over HOLD because nobody disputes the thesis itself; the holdouts are explicit that they want in, just not yet.
Key levels
Key levels · NOW
USD · as of 2026-08-02Analyst consensus target 140 USD · range 85–236
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
What legendary investors think
We ran ServiceNow, Inc. past a panel of 6 legendary investors' frameworks.
The panel · 6 investors
The Scuttlebutt Growth InvestorGrowth/Management🟢 BullishHigh
Signal: A 14/15 checklist score, a 98% renewal rate, 658 customers now paying over $5M ACV (+23% YoY), and a CEO who bought $3M of stock with his own money — <strong>the stock has fallen 53% from its high while subscription revenue grows 22% and free cash flow margins expand to 33%</strong>, a divergence between price and fundamentals this framework treats as opportunity, not warning. Conviction: Only equity dilution from stock-based compensation keeps this off a perfect score — a real, disclosed cost, but a second-order one against $4.58B of free cash flow.
The GARP OperatorGrowth (GARP)🟢 BullishMed
Signal: <strong>A PEG ratio near 1.0 on a 21% grower is the exact arithmetic this framework hunts for</strong> — forward P/E of 22–24x for a company adding $1B+ in AI-driven annual contract value ahead of its own schedule is growth at a genuinely reasonable price, not a story stock. Conviction: The 98% renewal rate is the "parking lot" evidence — customers aren't leaving — but the monthly downtrend means position sizing should build in stages, not all at once.
The Moat CompounderValue/Quality/Moat🟢 BullishMed
Signal: <strong>A 98% renewal rate and AI agents that deepen switching costs rather than eroding them</strong> mean the moat is widening even as the market prices in disruption — at 22–24x forward earnings and a 1.0 PEG, this is the most reasonable valuation the business has offered in years. Conviction: The balance-sheet shift to net debt post-Armis is a real change worth tracking, but manageable against $4.6B of free cash flow — not yet a reason to discount the moat itself.
The Disruptive-Innovation SeekerDisruptive Innovation🟢 BullishMed
Signal: <strong>AI net new ACV crossing $1B and agentic deployments growing 9x in nine months is the market underestimating platform lock-in, not confirming disruption</strong> — the "no-ticket" AI service desk opens the addressable base from IT professionals to every employee at Fortune 500 companies. Conviction: The valuation anomaly (24x forward earnings for 22% growth) only holds if OpenAI's "Presence" fails to win a marquee reference account — a real, still-open risk this lens is tracking, not dismissing.
The Forensic SkepticContrarian/Forensic🟢 BullishMed
Signal: <strong>The market is pricing in a competing AI platform that doesn't yet exist</strong> — no accounting red flags, clean revenue recognition, and a stock that sold off 7% on a clean beat-and-raise is the textbook contrarian setup: fear ahead of fact. Conviction: The balance sheet shift to modest net debt post-Armis is manageable given $4.58B FCF, and insider selling by non-CEO executives reads as routine diversification, not a signal — genuine caution would require seeing customers actually leave.
The Intrinsic-Value ModelerValuation/DCF⚫ NeutralMed
Signal: My base-case DCF lands at $125 — just 14% above the current $111.23 — so <strong>the stock has come a long way from a genuine bargain, and a company whose entire competitive position is being publicly questioned deserves a wider cushion than 14%</strong> before the price/value gap justifies acting. Conviction: The bear and base cases span $70 to $125, a genuinely wide range driven by one unresolved question — does ServiceNow keep its AI-workflow share — that the last two quarters haven't settled either way.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- Every voice agrees the Q2 print itself was clean and undisputed — subscription growth accelerating, cRPO holding near 20%, AI net new ACV crossing $1B ahead of the company's own target, and a 98% renewal rate that shows no sign of customer flight.
- Nobody on the panel treats the OpenAI "Presence" disruption fear as confirmed in the data — every voice, bullish or cautious, reads it as a narrative risk still being tested against actual customer behavior, not something the numbers currently support.
- The balance-sheet shift to modest net debt following the Armis acquisition is acknowledged by every voice as a real change, but none treat it as a solvency concern given free cash flow of $4.58B.
- The monthly chart's Stage 4 downtrend is a fact everyone cites, even the five bullish voices — the disagreement is over how much weight a technical pattern deserves against an accelerating fundamental picture.
The real debate
- The Scuttlebutt Growth Investor and The Forensic Skeptic both treat the post-earnings selloff itself as the buy signal — fear divorced from fact — while The Intrinsic-Value Modeler sees a recovery that has already closed most of the gap to fair value, leaving too thin a margin of safety for a name with a genuinely open competitive question.
- The Disruptive-Innovation Seeker frames AI agents as widening ServiceNow's moat (the platform becomes the operating system AI runs on), while the same OpenAI "Presence" threat that voice dismisses is exactly what keeps The Intrinsic-Value Modeler's bear case ($70) alive as a real, not token, scenario.
- The GARP Operator and The Moat Compounder both point to the sub-1.0 PEG as the valuation case closing, while the technical read insists the monthly downtrend hasn't confirmed a reversal — a tension between "the numbers already say buy" and "the tape hasn't said so yet."
The question it comes down to: Does ServiceNow's 12.6% recovery off the post-earnings low mark the start of a confirmed base — a monthly close above USD 133.19 that resolves the Stage 4 downtrend — or is the stock simply working off an overreaction with the harder technical and valuation confirmations still ahead?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 111.23 / ~USD 114.4B |
| P/E (TTM / fwd) | 69.1x / 24.4x |
| PEG ratio | ~0.99 |
| Renewal rate | 98% |
| ROE / ROIC (TTM) | 13.11% / 9.46% |
| AI net new ACV | Crossed USD 1B in Q2, on pace for the USD 1.5B FY26 target |
| Balance sheet | Net debt/equity ~0.30x (post-Armis acquisition; was net cash pre-acquisition) |
| Free cash flow | USD 4.58B (FY2025), ~33% FCF margin |
Figures as of 2026-08-02; price as of the 2026-07-31 close (USD 111.23); sourced from stockanalysis.com and ServiceNow's Q2 2026 earnings materials.
The bottom line
The panel's read on the business itself has barely moved in two weeks — it was strong on July 25 and it's strong now, with five of six archetypes calling it an outright buy on fundamentals. What keeps this WAIT is that the technical and valuation confirmations are still catching up to the fundamental case: the monthly chart remains in a Stage 4 downtrend that a 12.6% weekly bounce hasn't yet broken, and the stock's rally off its lows has already closed most of the gap to the most conservative fair-value estimate on the panel. A monthly close above USD 133.19 would resolve the technical objection directly; a pullback toward USD 90 would resolve the valuation one. On the downside, a renewal rate slipping below 95% or cRPO growth falling under 15% constant-currency would be the first sign the AI-disruption fear is more than a narrative — that's the number worth watching most closely into Q3 earnings in October.
contact@verdixhq.com · Published 2026-08-02 · Prices as of 2026-08-02 · Time horizon: 3–12 months · Founder holds a direct position in NOW · NOW verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
Why the panel isn’t ready to call NOW yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NYSE · Information Technology · 2026-08-08 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitMEDIUM confidence
Why
ServiceNow's business quality earns near-unanimous praise across our panel: genuine moat, $1 billion in AI contract value, and $4.58 billion in free cash flow. But with the stock perched on a precarious monthly technical inflection point and gross margins slipping, the debate is purely about price and timing, leaving the panel at WAIT until either a confirmed technical breakout above $133.51 or a better entry price materializes.Level to watch
Key resistance 126.4+1.2% from 124.88
Next catalyst
Bullish confirmation trigger: A weekly close above $133.51, the 200-week EMA coinciding with the monthly 61.8% Fibonacci retracement, would confirm the technical bottom and flip the cautious voices toward BUY.The panel's take
Verdict: WAIT · Conviction: MED · Last price: 124.88
What changed since 2026-08-02:
- Price: 111.23 → 124.88 (+12.27%)
- Panel: 5 of 6 → 4 of 6 now Bullish — composition also changed: added The Asymmetric Bargainer, The Quality Rationalist; removed The Disruptive-Innovation Seeker, The Moat Compounder
- Trigger: BUY trigger: a weekly close above $133.51 (weekly EMA200, which coincides with the monthly 61.8% Fib) confirming the technical bottom and reclaiming the long-term EMA; OR Q3 earnings showing gross margin stabilizing above 76%. SELL/deeper-WAIT trigger: a weekly close below $117.63 (monthly volume POC), confirming Stage 4 breakdown and targeting $104.25 next.
- Verdict: WAIT (unchanged)
The stock climbed 12.3% from $111.23 to $124.88 since the prior WAIT verdict, and the panel rotated: growth-oriented voices (Disruptive-Innovation Seeker, Moat Compounder) were replaced by valuation-disciplined ones (Asymmetric Bargainer, Quality Rationalist). The result is the same WAIT: the business case strengthened with another quarter of AI ACV growth and raised guidance, but the price now sits precisely at a monthly technical inflection point that could resolve sharply in either direction, and none of the cautious voices see enough evidence yet to declare the bottom confirmed.
The business quality is near-unanimous across all 9 voices: NOW is a wonderful company with a wide moat, accelerating AI monetization ($1B AI ACV), and strong free cash flow. But both cautious voices (technical-scout and The Forensic Skeptic) object on price/timing, not the business itself. The stock sits on a precarious monthly Stage 3→4 transition, hugging the weekly 61.8% Fib retracement ($124.59) that could resolve sharply in either direction. This is a textbook BUY vs WAIT split: all voices agree the business is sound, but the cautious camp wants either a confirmed technical bottom or a lower entry price. That synthesizes to WAIT, not HOLD.
Key levels
Key levels · NOW
USD · as of 2026-08-08Key support & resistance — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
What legendary investors think
We ran ServiceNow past a panel of 6 legendary investors' frameworks.
The panel · 6 investors
The Intrinsic-Value ModelerValuation/DCF⚫ Neutraln/a
Signal: A discounted cash flow model using conservative assumptions (22% revenue growth tapering to 15%, 25% steady-state margins, and a 9–10% cost of capital) yields an intrinsic value near $875, making the current $124.88 price <strong>a ~600% disconnect from estimated worth</strong> for a business generating $4.58B in annual free cash flow. Conviction: The incomplete technical assessment and the extreme magnitude of the value gap restrain conviction here, raising the unresolved question of whether the model properly accounts for AI-driven competitive risk.
The GARP OperatorGrowth (GARP)🟢 BullishMed
Signal: Forward P/E of ~28x against ~20% EPS growth produces a PEG ratio near <strong>1.0 to 1.1</strong>, and free cash flow of $4.58B runs 2.7 times reported net income, a hallmark of genuine earnings quality that the framework prizes. Conviction: Gross margin erosion from 77.5% to 74.8% holds this back, a single contested trend that could unravel the growth story if it persists for two more quarters.
The Scuttlebutt Growth InvestorGrowth/Management🟢 BullishHigh
Signal: The company scores <strong>15 out of 15</strong> on the scuttlebutt checklist, with AI annual contract value crossing $1 billion, 123 deals over $1 million net new ACV (up 40% year-over-year), and $29 billion in remaining performance obligations confirming deep enterprise lock-in. Conviction: Multiple independent confirmations elevate conviction: customer commitments, management transparency, and free-cash-flow quality all point in the same direction, with no single contested assumption undermining the thesis.
The Asymmetric BargainerContrarian/Deep Value🟢 BullishMed
Signal: The Dhandho framework identifies a perception-vs-reality gap: the market is pricing a mature SaaS company facing disruption, yet the business generates <strong>$4.58 billion in free cash flow</strong> on a ~$130 billion market cap, with AI accelerating rather than commoditizing the platform. Conviction: The Dhandho score of only 2.5 out of 4 tempers conviction: the setup lacks the 'maximum pessimism' required for a high-conviction bet, with 89% of analysts already rating it a Buy.
The Quality RationalistMental Models/Quality🟢 BullishMed
Signal: High switching costs make ServiceNow's 39% drawdown look like an opportunity a long-term compounder should take, not a reason to run: <strong>free cash flow of $4.58 billion is 2.7 times reported net income</strong>, confirming outstanding earnings quality behind that moat. Conviction: An unresolved dependency caps conviction at 70%: the AI technology stack sits outside the circle of competence, making it impossible to independently verify whether the AI moat is durable or a temporary lead.
The Forensic SkepticContrarian/Forensic⚫ NeutralMed
Signal: Stock-based compensation of $1.9 billion, when subtracted from headline free cash flow, reduces real FCF to approximately $2.7 billion, and <strong>gross margin slid 270 basis points</strong> from 77.5% to 74.8% in a single quarter, a trend that makes the consensus 20% EPS CAGR look fragile. Conviction: What limits conviction is a single contested assumption: whether the 89% analyst Buy rating and 26% consensus upside represent an opportunity rather than a contrarian warning that surprises are more likely to the downside.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- All six voices agree ServiceNow is a high-quality business with a genuine competitive moat built on enterprise switching costs and deep platform integration.
- The $1 billion AI ACV milestone is tangible proof that AI monetization is real, not vaporware, and is accelerating rather than disrupting the core business.
- Free cash flow generation is outstanding across every framework, with the $4.58 billion annual figure cited repeatedly as a sign of durable business strength.
- The 39% price decline over 52 weeks has meaningfully compressed the valuation from historical highs, bringing the forward P/E to ~28x and the PEG ratio near 1.0.
The real debate
- The Intrinsic-Value Modeler sees a ~600% value gap while The Forensic Skeptic calculates only an 8% margin of safety, a stark disagreement on what the business is actually worth, driven by entirely different assumptions about normalized multiples and competitive fade.
- The Scuttlebutt Growth Investor sees a rare 15/15 checklist score and a compressed valuation worth acting on, while The Forensic Skeptic sees dangerous one-sided consensus (89% Buy ratings) and a fragile monthly technical structure that warns of further downside.
- The Asymmetric Bargainer views the 39% decline as creating a perception-vs-reality gap worth exploiting with a starter position, while The Forensic Skeptic argues the stock hasn't fallen far enough: true maximum pessimism would require a pullback toward $100 or lower.
The question it comes down to: Does the technical setup at the 61.8% Fibonacci retracement and the uncertain gross-margin trajectory represent a rare opportunity to buy a wonderful compounder at a compressed multiple, or are they early warnings that the AI investment cycle will keep pressure on profitability long enough to justify waiting for a confirmed bottom?
The bottom line
- Bullish confirmation trigger: A weekly close above $133.51, the 200-week EMA coinciding with the monthly 61.8% Fibonacci retracement, would confirm the technical bottom and flip the cautious voices toward BUY.
- Breakdown risk to monitor: A weekly close below $117.63 (the monthly volume point of control) would confirm a Stage 4 breakdown with the next historical accumulation zone at $104.25.
- Margin stabilization catalyst: Q3 earnings in October must show gross margin stabilizing above 76%; another quarter of compression below 74% would validate The Forensic Skeptic's core concern and likely drive a re-rating lower.
- Further out: cRPO growth sustaining above 20% through fiscal 2027 would confirm that AI is additive to the growth trajectory rather than merely offsetting core ITSM maturation.
contact@verdixhq.com · Published 2026-08-08 · Prices as of 2026-08-08 · Time horizon: 3–12 months · Founder holds a direct position in NOW · NOW verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
Why the panel isn’t ready to call NOW yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NYSE · Information Technology · 2026-08-15 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitHIGH confidence
Why
ServiceNow's business quality is undeniable — a wide moat, exceptional free cash flow, and a real AI tailwind — but a panel of five distinct analytical frameworks unanimously refuses to buy at $124. The debate is not about whether the company will thrive but whether the price already assumes it will, and until either a breakout above $133 or a pullback toward $100 resolves the standoff, the verdict is a high-conviction WAIT.Level to watch
Key resistance 126.65+2.1% from 124
Next catalyst
Trigger to confirm the breakout: A weekly close above $133 (the EMA200) with expanding volume would shift every cautious voice, confirming the Stage 4 downtrend has ended and the weekly base has resolved upward.The panel's take
Verdict: WAIT · Conviction: HIGH · Last price: 124.0
What changed since 2026-08-08:
- Price: 124.88 → 124.0 (-0.70%)
- Panel: 4 of 6 → 0 of 5 now Bullish — composition also changed: added The Moat Compounder; removed The Asymmetric Bargainer, The Quality Rationalist
- Trigger: BUY trigger: a weekly close above $133 (EMA200) with expanding volume, confirming the Stage 4 → Stage 2 transition, OR a pullback to the $100-$110 zone (near volume POC at $103) where The Intrinsic-Value Modeler, The Moat Compounder, and The Scuttlebutt Growth Investor all see margin of safety. Management open-market purchases would significantly boost confidence. SELL trigger: a weekly close below $103 (volume POC) breaking the basing thesis, or another quarter of negative EPS growth with revenue deceleration below 20%.
- Verdict: WAIT (unchanged)
The panel's conviction hardened from MEDIUM to HIGH and the bullish contingent evaporated entirely, not because the business deteriorated — revenue growth held at 24%, free cash flow remains exceptional — but because three months of price action at $124 failed to resolve the technical standoff below $126–$133 resistance, insiders continued selling without a single purchase, and the EPS decline persisted without clarity on when earnings turn positive. The previous panel gave the bulls the benefit of the doubt; this one does not.
Every cautious voice — The GARP Operator, The Intrinsic-Value Modeler, The Scuttlebutt Growth Investor, and The Moat Compounder — explicitly states the business is excellent (wide moat, strong FCF, AI tailwind) but the price is wrong. Zero voices argue the company itself is broken. The split is purely BUY vs WAIT: the bulls (sentiment-scout, fundamental-scout) see a great company; the cautious camp wants either a lower price ($90-$110 range) or a confirmed trend reversal above $126-$133. There is no genuine SELL case against the business — even The Forensic Skeptic, the most bearish voice, doesn't call it a short. This is a textbook WAIT.
Key levels
Key levels · NOW
USD · as of 2026-08-15Key support & resistance — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
What legendary investors think
We ran ServiceNow past a panel of 5 legendary investors' frameworks.
The panel · 5 investors
The GARP OperatorGrowth (GARP)⚫ NeutralMed
Signal: ServiceNow's $1 billion in AI-related contract value growing 40% sequentially is a real catalyst, but EPS fell 22.6% this quarter and I cannot buy a growth story when the earnings are going backward. Conviction: Conviction is held back because the monthly chart remains in a Stage 4 downtrend and insiders are selling with zero open-market purchases — two hard facts that will not resolve until either the stock clears $133 on volume or management starts buying.
The Intrinsic-Value ModelerValuation/DCF⚫ NeutralLow
Signal: At $124 the market is already embedding a decade of 20%+ growth and terminal margins above 25%, yet my base-case fair value sits at $105, which means the current price offers negative 15% upside even under generous assumptions. Conviction: Multiple independent checks — the divergence between 24% revenue growth and negative EPS, insider selling with no open-market purchases, and a monthly chart still in Stage 4 — converge on the same conclusion, pushing conviction high that waiting is the right call.
The Forensic SkepticContrarian/Forensic🔴 BearishMed
Signal: ROIC collapsed from 47% to 16% in a single quarter while 35 of 42 analysts still say Buy and news sentiment sits at an euphoric 0.91 — that is the kind of crowded consensus I have built a career avoiding. Conviction: Conviction strengthens because the red flags are stacked: zero insider buying, a monthly MACD that remains bearish, and a trailing P/E of 77x for a company whose earnings just shrank — no single assumption needs to break for this to go wrong.
The Scuttlebutt Growth InvestorGrowth/Management⚫ NeutralMed
Signal: The scuttlebutt is strong — broad-based demand, a 31% free cash flow margin, and a leadership position in ITSM — but the complete absence of any open-market insider purchases conflicts directly with the euphoric 35-of-42 Buy ratings and tells me the price is not yet right. Conviction: What holds conviction back from flipping bullish is that the company passes 11 of my 15 points yet the technical structure remains broken below $126, so I need either a confirmed base or a pullback to the $103 volume POC before the business quality translates into a purchase.
The Moat CompounderValue/Quality/Moat⚫ NeutralMed
Signal: The moat is genuine — switching costs in enterprise IT service management are enormous and free cash flow of $5.3 billion converts at 3x net income — but 27x forward earnings for a company whose ROIC just dropped from 47% to 16.5% is not a fair price, no matter how wonderful the business. Conviction: Conviction sits at 60% because the business-quality signals (recurring revenue, 75% gross margins, negligible net debt) are strong but the price-discipline signals (Stage 4 monthly trend, insider silence, ROIC deterioration) are equally loud, and the tiebreaker has not yet arrived.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- ServiceNow's core business quality is not in dispute: every voice on the panel acknowledges the wide moat from switching costs, the 31% free cash flow margin, and the genuine AI tailwind.
- No one sees a reason to short the stock — even The Forensic Skeptic, the most bearish voice, explicitly declines to call it a short.
- All four cautious voices converge on the same price zone of interest: the $100–$110 range near the volume POC at $103, where margin of safety would shift the calculus.
- Insider behavior is a universal concern — zero open-market purchases in 90 days while directors and officers sold nearly $1.8M registers as a yellow-to-red flag across every archetype.
The real debate
- The Forensic Skeptic and The Moat Compounder see the ROIC collapse from 47% to 16% as a structural warning that capital efficiency is deteriorating, while The Scuttlebutt Growth Investor and The GARP Operator view it as a temporary investment phase that will pay off if the AI pipeline converts.
- The Intrinsic-Value Modeler frames the debate as a pure numbers problem — $105 fair value versus $124 price means negative expected return — whereas The Scuttlebutt Growth Investor frames it as a timing problem: 11 of 15 checklist points passed, but the price must cooperate first.
- No archetype is actively bullish at $124. In the prior panel, four voices were bullish; this time zero are. The disagreement is only about what price or signal would unlock the buy — $90–$100 for the value-conscious, $126–$133 for the trend-confirmation camp.
The question it comes down to: Will ServiceNow's AI investment cycle translate into reaccelerating EPS before the premium valuation compresses, or will the stock first revisit the $100–$110 zone where the margin of safety actually exists?
The bottom line
- Trigger to confirm the breakout: A weekly close above $133 (the EMA200) with expanding volume would shift every cautious voice, confirming the Stage 4 downtrend has ended and the weekly base has resolved upward.
- Price zone for margin of safety: A pullback into the $100–$110 range, anchored by the volume POC at $103, would satisfy The Intrinsic-Value Modeler, The Moat Compounder, and The Scuttlebutt Growth Investor simultaneously, flipping the panel toward Buy.
- Risk to monitor: A weekly close below $103 breaks the basing thesis entirely and would push The Intrinsic-Value Modeler's fair value toward $75–$85, turning the WAIT into a structural caution.
- Next catalyst: The upcoming earnings report must answer whether the EPS decline of 22.6% was a one-quarter investment spike or the start of a trend; a second consecutive quarter of negative EPS growth with revenue deceleration below 20% would break the bull case.
contact@verdixhq.com · Published 2026-08-15 · Prices as of 2026-08-15 · Time horizon: 3–12 months · Founder holds a direct position in NOW · NOW verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel’s case for NOW — and where they disagree.
The case for outweighs the case against at today's price.
NYSE · Information Technology · 2026-08-22 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
BuyLOW confidence
Why
ServiceNow splits the panel along a single fault line — business quality versus entry price. Four archetypes see enough AI-fueled upside above $150 to call $128 a buy, while one bear and one bargain-hunter insist that 80x trailing earnings and zero insider buying leave no margin of safety. The debate turns on whether a confirmed technical breakout above $133 or a pullback toward $110 comes first.Level to watch
Key support 124.59−3.0% from 128.48
Next catalyst
Confirmation trigger to watch: A weekly close above $133 with expanding volume would confirm the base breakout and lift conviction across the GARP, intrinsic-value, and disruptive-innovation frameworks simultaneously.The panel's take
Verdict: BUY · Conviction: LOW · Last price: 128.48 · Changed from WAIT
Panel: 4 Bullish · 1 Neutral · 1 Bearish → BUY
What changed since 2026-08-15:
- Price: 124.0 → 128.48 (+3.61%)
- Panel: 0 of 5 → 4 of 6 now Bullish — composition also changed: added The Asymmetric Bargainer, The Disruptive-Innovation Seeker; removed The Moat Compounder
- Trigger: A weekly close below $124.59 (the weekly 61.8% Fibonacci retracement and the level the technical scout, The GARP Operator, and The Intrinsic-Value Modeler all cite as the line where the recovery rally is invalidated) would flip this to WAIT or SELL. The prior BUY trigger — a weekly close above $133 with expanding volume — remains the standing confirmation level and would raise conviction if fired.
- Verdict: WAIT → BUY
The prior WAIT hinged on a technical breakout trigger — a weekly close above $133 — that has not yet fired. What changed is the panel's composition and the weight of fundamental conviction: two new voices (The Asymmetric Bargainer and The Disruptive-Innovation Seeker) joined, and the intrinsic-value and scuttlebutt cases each landed above $155, giving four of six archetypes a framework-level reason to treat $128 as a buy despite the un-fired trigger. The sole bear objects on valuation, not business quality, which is why the panel can flip to BUY even though the technical scout's WAIT condition remains unmet.
The prior WAIT trigger — a weekly close above $133 — has not yet fired (price sits at $128.48), so the buy-on-breakout condition remains unmet. However, the panel flips to BUY anyway because four of six voices now see the reward skewed sufficiently upward at $128: The Intrinsic-Value Modeler and The Scuttlebutt Growth Investor each value the business above $155, the Disruptive-Innovation Seeker bull case is $350, and The GARP Operator sees a PEG of 1.16 on a 20% compounder as his sweet spot. The sole bear, The Forensic Skeptic, objects on price rather than business quality — arguing $128 offers no margin of safety against 80x trailing earnings and zero insider buying — not that the franchise is broken. His dissent is a valuation-only objection, and it is the only bearish voice on a panel where the neutral (The Asymmetric Bargainer) also frames his caution entirely around entry price. The verdict is BUY because the preponderance of fundamental conviction overcomes the technical scout's tactical WAIT and the un-fired breakout trigger.
Key levels
Key levels · NOW
USD · as of 2026-08-22Analyst consensus target 142.23 USD · range 72–248
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key resistance sits at $133.19 — the monthly 61.8% Fibonacci retracement and the level five voices flagged as the make-or-break breakout point — followed by $139.07 (monthly EMA20), which would signal a full return to Weinstein Stage 2 on a monthly close. Key support at $124.59 (weekly 61.8% Fib) is the first tripwire; a weekly close below that fractures the recovery thesis shared by the technical scout, The GARP Operator, and The Intrinsic-Value Modeler. Below it, the historical accumulation zone at $117.63 (monthly volume POC) is the next structural floor. The analyst consensus target of $142.23 sits 10.7% above the current price, implying the Street sees room to run but not dramatically so at these levels.
What legendary investors think
We ran ServiceNow past a panel of 6 legendary investors' frameworks.
The panel · 6 investors
The GARP OperatorGrowth (GARP)🟢 BullishMed
Signal: With a PEG of 1.16 on a 20% compounder whose $29 billion in remaining performance obligations grew 21% year-over-year, the growth is already locked in at a price that sits squarely in the sweet spot. Conviction: Conviction is tempered because every single insider transaction over the last 90 days has been a sale — zero open-market purchases — which leaves the signal entirely one-sided on a stock still 32% off its highs.
The Intrinsic-Value ModelerValuation/DCF🟢 BullishMed
Signal: The base-case DCF lands at $155, implying 20.6% upside from $128.48, built on a 22% revenue CAGR that decays to 15% and a 35% target operating margin — assumptions the $1 billion AI ACV milestone makes defensible rather than aspirational. Conviction: Conviction is held back because the terminal value hinges on a 35% margin that is still 22.6 percentage points above today's 12.4% reality, making the valuation a bet on execution spread across years.
The Scuttlebutt Growth InvestorGrowth/Management🟢 BullishMed
Signal: The 15-point checklist scores 13 out of 15, with AI annual contract value crossing $1 billion and agentic deployments multiplying ninefold in nine months, confirming that the product pipeline is not just theoretical but converting into locked-in customer commitments. Conviction: Conviction stays at moderate because scuttlebutt on labor relations and executive depth is entirely absent from the evidence file, leaving two checklist items unverified rather than affirmatively passed.
The Forensic SkepticContrarian/Forensic🔴 BearishLow
Signal: At $128.48, the stock carries negative tangible book value of $1.07 per share and zero insider purchases across 50 transactions, meaning there is no asset floor and no management-skin-in-the-game to cushion an investor if the 80x trailing multiple compresses. Conviction: The bearish read is not a blanket short call — the business throws off real cash — but there is no margin of safety at this price, and until that changes, the framework says wait.
The Disruptive-Innovation SeekerDisruptive Innovation🟢 BullishMed
Signal: ServiceNow's AI annual contract value crossed $1 billion while agentic deployments surged 9x in nine months, placing the platform in the early-adoption phase of a $500 billion TAM where Wright's Law dynamics on inference costs expand the addressable market exponentially. Conviction: Conviction runs higher than most on the panel because the S-curve evidence is unusually concrete — $29 billion in RPO and 84% institutional ownership are not speculative footnotes, they are hard commitments.
The Asymmetric BargainerContrarian/Deep Value⚫ NeutralLow
Signal: The Dhandho test fails on the critical second question: at 80x trailing earnings with downside to $83 in a bear case, the 'tails I don't lose much' structure is absent, even though the business quality is excellent and the revenue trajectory is intact. Conviction: Conviction stays neutral because the gap between a weak stock price and strong fundamentals is real, but it is already partially priced in — this is not a distressed Patel motel, it is a premium franchise trading at a premium.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- Every voice on the panel agrees the underlying business is high-quality: 20%+ revenue growth, 77% gross margins, $29 billion in RPO, and a wide moat built on enterprise switching costs.
- The AI story is real and measurable — $1 billion in AI ACV and a 9x surge in agentic deployments are concrete, not vaporware.
- Insider behavior is a universal concern: zero open-market purchases and $277K in net sales across 90 days is flagged by every archetype as a signal that management does not see the stock as cheap.
- The weekly chart is improving (MACD turning positive, price above EMA50), but the monthly trend remains bearish — technical recovery is preliminary, not confirmed.
The real debate
- The Intrinsic-Value Modeler and The Disruptive-Innovation Seeker see reward skewed sufficiently upward at $128 — one values the business at $155 in a base case, the other at $350 in a five-year probability-weighted framework — while The Forensic Skeptic sees intrinsic value closer to $110 and insists there is no margin of safety.
- The Asymmetric Bargainer and The Forensic Skeptic both object on price, but they differ on remedy: the former wants a pullback to $100–110 for a proper Dhandho entry, while the latter needs $90–100 and insider buying before the framework turns constructive.
- The GARP Operator treats a PEG of 1.16 on a 20% compounder as a fair entry, while The Asymmetric Bargainer counters that 80x trailing earnings means the downside in a compression scenario is severe, not limited — the same metric, two irreconcilable readings.
The question it comes down to: Does the AI monetization trajectory justify paying a forward multiple that assumes nearly flawless execution, or is the absence of any margin of safety at 80x trailing earnings reason enough to wait for a better price?
The bottom line
- Confirmation trigger to watch: A weekly close above $133 with expanding volume would confirm the base breakout and lift conviction across the GARP, intrinsic-value, and disruptive-innovation frameworks simultaneously.
- Line in the sand: A weekly close below $124.59 — the 61.8% Fibonacci retracement — would invalidate the recovery rally for the three archetypes that cite it and likely flip the panel back to WAIT or SELL.
- Insider signal to monitor: The first open-market insider purchase, especially by the CEO or CFO at current levels, would neutralize the universal bearish flag and could shift the neutral and skeptical voices toward constructive.
- Next catalyst: Q3 2026 earnings in late October are the nearest hard data point — any guidance revision, up or down, will reset the forward P/E that underpins the GARP and intrinsic-value bull cases.
- Further out: A quarter with subscription revenue growth accelerating above 25% would validate the Disruptive-Innovation Seeker's S-curve thesis and could draw the Asymmetric Bargainer off the sidelines if the stock has not already run.
contact@verdixhq.com · Published 2026-08-22 · Prices as of 2026-08-22 · Time horizon: 3–12 months · No direct position held in NOW · NOW verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel also debated